BRAF c.1794T>G ;(p.A598=)

Variant ID: 7-140453141-A-C

NM_004333.4(BRAF):c.1794T>G;(p.A598=)

This variant was identified in 7 publications

View GRCh38 version.




Publications:


Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer.

Nature Communications
Boström, Martin M; Larsson, Erik E
Publication Date: 2022-11-17

Variant appearance in text: BRAF: A598A
PubMed Link: 36396655
Variant Present in the following documents:
  • 41467_2022_34746_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page



mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis.

Cell Reports
Triki, Mouna M; Rinaldi, Gianmarco G; Planque, Melanie M; Broekaert, Dorien D; Winkelkotte, Alina M AM; Maier, Carina R CR; Janaki Raman, Sudha S; Vandekeere, Anke A; Van Elsen, Joke J; Orth, Martin F MF; Grünewald, Thomas G P TGP; Schulze, Almut A; Fendt, Sarah-Maria SM
Publication Date: 2020-06-23

Variant appearance in text: BRAF: A598A
PubMed Link: 32579932
Variant Present in the following documents:
  • mmc5.xlsx, sheet 3
View BVdb publication page



Lack of Response to Vemurafenib in Melanoma Carrying BRAF K601E Mutation.

Case Reports In Oncology
Moiseyenko, Fedor V FV; Egorenkov, Vitaliy V VV; Kramchaninov, Mikhail M MM; Artemieva, Elizaveta V EV; Aleksakhina, Svetlana N SN; Holmatov, Maxim M MM; Moiseyenko, Vladimir M VM; Imyanitov, Evgeny N EN
Publication Date: 2019

Variant appearance in text: BRAF: A598A
PubMed Link: 31182949
Variant Present in the following documents:
  • Main text
  • cro-0012-0339.pdf
View BVdb publication page



Beyond KRAS: Practical Molecular Targets in Pancreatic Adenocarcinoma.

Case Reports In Oncology
Grinshpun, Albert A; Zarbiv, Yonaton Y; Roszik, Jason J; Subbiah, Vivek V; Hubert, Ayala A
Publication Date: 2019

Variant appearance in text: BRAF: A598A
PubMed Link: 30792639
Variant Present in the following documents:
  • Main text
  • cro-0012-0007.pdf
View BVdb publication page



Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.

Plos One
Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS
Publication Date: 2018

Variant appearance in text: BRAF: A598A
PubMed Link: 29698444
Variant Present in the following documents:
  • pone.0196434.s001.xlsx, sheet 2
  • pone.0196434.s001.xlsx, sheet 3
  • pone.0196434.s001.xlsx, sheet 1
View BVdb publication page



Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care.

Bmc Cancer
Heppt, Markus V MV; Siepmann, Timo T; Engel, Jutta J; Schubert-Fritschle, Gabriele G; Eckel, Renate R; Mirlach, Laura L; Kirchner, Thomas T; Jung, Andreas A; Gesierich, Anja A; Ruzicka, Thomas T; Flaig, Michael J MJ; Berking, Carola C
Publication Date: 2017-08-10

Variant appearance in text: BRAF: A598A
PubMed Link: 28797232
Variant Present in the following documents:
  • Main text
  • 12885_2017_Article_3529.pdf
View BVdb publication page



Longitudinal analysis of treatment-induced genomic alterations in gliomas.

Genome Medicine
Erson-Omay, E Zeynep EZ; Henegariu, Octavian O; Omay, S Bülent SB; Harmancı, Akdes Serin AS; Youngblood, Mark W MW; Mishra-Gorur, Ketu K; Li, Jie J; Özduman, Koray K; Carrión-Grant, Geneive G; Clark, Victoria E VE; Çağlar, Caner C; Bakırcıoğlu, Mehmet M; Pamir, M Necmettin MN; Tabar, Viviane V; Vortmeyer, Alexander O AO; Bilguvar, Kaya K; Yasuno, Katsuhito K; DeAngelis, Lisa M LM; Baehring, Joachim M JM; Moliterno, Jennifer J; Günel, Murat M
Publication Date: 2017-02-02

Variant appearance in text: BRAF: A598A
PubMed Link: 28153049
Variant Present in the following documents:
  • 13073_2017_401_MOESM3_ESM.xlsx, sheet 2
View BVdb publication page